Skip to main content
Clinical Trials/NCT01542580
NCT01542580
Active, not recruiting
Not Applicable

A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee

Zimmer Biomet12 sites in 8 countries255 target enrollmentMarch 1, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Zimmer Biomet
Enrollment
255
Locations
12
Primary Endpoint
AMERICAN KNEE SOCIETY KNEE SCORE
Status
Active, not recruiting
Last Updated
5 months ago

Overview

Brief Summary

The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.

Detailed Description

This investigation is being conducted on a new complete revision knee system, Vanguard 360, which incorporates: * Fixed Bearing Knee - Vanguard SSK360 with PS Bearing and PSC Bearing * Fixed Bearing Knee - Vanguard SSK360 TiNbN Femur with PS Bearing and PSC Bearing * Mobile Bearing Knee - Vanguard DA360 (only being collected in Europe) The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship. The efficacy and performance of the devices will be assessed by improvement of pain, function, range of motion and patient satisfaction measured pre-operatively and post-operatively. Secondary performance and safety will be determined by radiographic investigation, incidence of complications and revision rates. Surgical techniques and patient care are to be standard for the surgeon participating in the protocol. There will be no experimental or investigational devices used. There will be no experimental or investigational surgical techniques used. The devices and products will be used in accordance with their instructions for use and/or approved labeling.

Registry
clinicaltrials.gov
Start Date
March 1, 2012
End Date
December 1, 2031
Last Updated
5 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
  • Correction of varus, valgus or post-traumatic deformity
  • Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure
  • Ability and willingness of the patient to attend follow-up visit.
  • Willing to give written informed consent
  • Patients are at least 18 years of age, no upper age limit, must have reached full skeletal maturity.

Exclusion Criteria

  • infection
  • osteomyelitis
  • Relative Contraindications:
  • An uncooperative patient or a patient with neurologic disorders who is incapable of following directions
  • Osteoporosis
  • Metabolic disorders which may impair brain function
  • Osteomalacia
  • Distant foci of infections which may spread to the implant site
  • Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram
  • Vascular insufficiency, muscular atrophy, neuromuscular disease

Outcomes

Primary Outcomes

AMERICAN KNEE SOCIETY KNEE SCORE

Time Frame: 24 months postoperative

Improvement of American Knee Society Knee Score between pre-operative and 2 years post-operative follow up

Secondary Outcomes

  • Survivorship(10 years postoperative)

Study Sites (12)

Loading locations...

Similar Trials